 Ann Reynolds
Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 7 | 2025 | 423 | 1.940 |
Why?
| | Sleep Initiation and Maintenance Disorders | 3 | 2019 | 196 | 0.980 |
Why?
| | Child Development Disorders, Pervasive | 3 | 2013 | 65 | 0.780 |
Why?
| | Antipsychotic Agents | 1 | 2025 | 211 | 0.770 |
Why?
| | Autistic Disorder | 3 | 2019 | 219 | 0.770 |
Why?
| | Ambulatory Care Facilities | 1 | 2025 | 269 | 0.750 |
Why?
| | Developmental Disabilities | 4 | 2025 | 281 | 0.710 |
Why?
| | Drug Monitoring | 1 | 2025 | 401 | 0.690 |
Why?
| | Sleep Wake Disorders | 2 | 2019 | 314 | 0.680 |
Why?
| | Ferrous Compounds | 1 | 2019 | 25 | 0.600 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2026 | 420 | 0.410 |
Why?
| | Infant, Premature | 5 | 2026 | 620 | 0.410 |
Why?
| | Neonatal Abstinence Syndrome | 2 | 2024 | 27 | 0.390 |
Why?
| | Child Development | 4 | 2026 | 483 | 0.350 |
Why?
| | Severity of Illness Index | 4 | 2023 | 2933 | 0.320 |
Why?
| | Pediatrics | 1 | 2019 | 1125 | 0.320 |
Why?
| | Hydrocortisone | 3 | 2026 | 298 | 0.310 |
Why?
| | Child, Preschool | 11 | 2026 | 11868 | 0.310 |
Why?
| | Hypoxia-Ischemia, Brain | 2 | 2025 | 50 | 0.310 |
Why?
| | Hypothermia, Induced | 2 | 2025 | 96 | 0.300 |
Why?
| | Infant, Premature, Diseases | 3 | 2025 | 113 | 0.290 |
Why?
| | Diet | 2 | 2025 | 1278 | 0.280 |
Why?
| | Child | 14 | 2026 | 22740 | 0.280 |
Why?
| | Nutrition Assessment | 1 | 2008 | 90 | 0.270 |
Why?
| | Eating | 2 | 2023 | 387 | 0.270 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2008 | 106 | 0.260 |
Why?
| | Sleep | 3 | 2023 | 889 | 0.250 |
Why?
| | Infant, Newborn | 13 | 2026 | 6465 | 0.240 |
Why?
| | Darbepoetin alfa | 1 | 2025 | 3 | 0.230 |
Why?
| | Hematinics | 1 | 2025 | 22 | 0.230 |
Why?
| | Neuroprotection | 1 | 2025 | 46 | 0.220 |
Why?
| | Anti-Inflammatory Agents | 2 | 2026 | 478 | 0.210 |
Why?
| | Ataxia | 3 | 2009 | 69 | 0.200 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2024 | 41 | 0.200 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2023 | 70 | 0.190 |
Why?
| | Male | 22 | 2026 | 73011 | 0.190 |
Why?
| | Feeding Behavior | 1 | 2008 | 692 | 0.180 |
Why?
| | Double-Blind Method | 3 | 2025 | 2064 | 0.180 |
Why?
| | Humans | 29 | 2026 | 145783 | 0.180 |
Why?
| | Female | 19 | 2026 | 79045 | 0.180 |
Why?
| | Milk, Human | 1 | 2024 | 175 | 0.180 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2023 | 185 | 0.160 |
Why?
| | Intensive Care Units, Neonatal | 3 | 2024 | 293 | 0.150 |
Why?
| | Economics, Behavioral | 1 | 2019 | 7 | 0.150 |
Why?
| | Ferritins | 1 | 2019 | 70 | 0.150 |
Why?
| | Deductibles and Coinsurance | 1 | 2019 | 12 | 0.150 |
Why?
| | Steroids | 1 | 2019 | 160 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2025 | 3634 | 0.130 |
Why?
| | Fragile X Syndrome | 2 | 2009 | 119 | 0.130 |
Why?
| | Tremor | 2 | 2009 | 98 | 0.130 |
Why?
| | Insurance Coverage | 1 | 2019 | 244 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2019 | 6085 | 0.120 |
Why?
| | Diet Records | 2 | 2025 | 89 | 0.120 |
Why?
| | Fetal Blood | 2 | 2015 | 327 | 0.120 |
Why?
| | Micronutrients | 2 | 2025 | 102 | 0.120 |
Why?
| | Infant | 7 | 2025 | 10091 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2015 | 50 | 0.110 |
Why?
| | Comorbidity | 2 | 2018 | 1662 | 0.110 |
Why?
| | Chorioamnionitis | 1 | 2015 | 50 | 0.110 |
Why?
| | Lymphocytes | 1 | 2016 | 376 | 0.100 |
Why?
| | Executive Function | 2 | 2009 | 470 | 0.100 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 181 | 0.100 |
Why?
| | Energy Intake | 2 | 2025 | 512 | 0.100 |
Why?
| | Stereotypic Movement Disorder | 1 | 2013 | 10 | 0.100 |
Why?
| | Deficiency Diseases | 1 | 2012 | 10 | 0.090 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 420 | 0.090 |
Why?
| | Brain | 1 | 2025 | 2969 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 3916 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2015 | 507 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2015 | 411 | 0.090 |
Why?
| | Disease Management | 1 | 2015 | 653 | 0.090 |
Why?
| | Program Evaluation | 1 | 2015 | 944 | 0.080 |
Why?
| | Saliva | 1 | 2013 | 249 | 0.080 |
Why?
| | Chromosomes, Human, X | 2 | 2008 | 77 | 0.080 |
Why?
| | Premature Birth | 1 | 2015 | 390 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2015 | 780 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2026 | 5428 | 0.080 |
Why?
| | Birth Weight | 2 | 2024 | 517 | 0.080 |
Why?
| | Pilot Projects | 1 | 2016 | 1898 | 0.080 |
Why?
| | Nutritional Status | 1 | 2012 | 353 | 0.080 |
Why?
| | Infant, Extremely Premature | 2 | 2024 | 68 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1777 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 923 | 0.070 |
Why?
| | Circadian Rhythm | 1 | 2013 | 513 | 0.070 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 37 | 0.070 |
Why?
| | Dairy Products | 1 | 2008 | 30 | 0.070 |
Why?
| | Nutritional Requirements | 1 | 2008 | 78 | 0.070 |
Why?
| | Dietary Fiber | 1 | 2008 | 59 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 990 | 0.070 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 69 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 91 | 0.070 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 147 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2015 | 2050 | 0.060 |
Why?
| | Dietary Proteins | 1 | 2008 | 135 | 0.060 |
Why?
| | Cognition Disorders | 2 | 2009 | 544 | 0.060 |
Why?
| | Adolescent | 2 | 2025 | 22577 | 0.060 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 199 | 0.060 |
Why?
| | Dietary Fats | 1 | 2008 | 308 | 0.060 |
Why?
| | Activities of Daily Living | 1 | 2009 | 444 | 0.060 |
Why?
| | Heterozygote | 1 | 2007 | 314 | 0.060 |
Why?
| | Point Mutation | 1 | 2007 | 241 | 0.060 |
Why?
| | Erythrocyte Count | 1 | 2025 | 21 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2875 | 0.060 |
Why?
| | Analgesics, Opioid | 2 | 2024 | 1154 | 0.050 |
Why?
| | Dietary Supplements | 1 | 2008 | 584 | 0.050 |
Why?
| | Infant Formula | 1 | 2024 | 71 | 0.050 |
Why?
| | Patient Comfort | 1 | 2023 | 12 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2012 | 5925 | 0.050 |
Why?
| | United States | 4 | 2025 | 16126 | 0.050 |
Why?
| | Narcotics | 1 | 2023 | 58 | 0.050 |
Why?
| | Sex Factors | 1 | 2008 | 2110 | 0.040 |
Why?
| | Time Factors | 3 | 2023 | 7134 | 0.040 |
Why?
| | Age Factors | 1 | 2008 | 3346 | 0.040 |
Why?
| | Breast Feeding | 1 | 2024 | 447 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2023 | 409 | 0.040 |
Why?
| | Parents | 1 | 2008 | 1407 | 0.040 |
Why?
| | Methylprednisolone | 1 | 2019 | 59 | 0.040 |
Why?
| | New York | 1 | 2019 | 128 | 0.040 |
Why?
| | Prospective Studies | 2 | 2026 | 8078 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1171 | 0.040 |
Why?
| | Quality of Life | 1 | 2011 | 3211 | 0.030 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 107 | 0.030 |
Why?
| | Habits | 1 | 2018 | 52 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2026 | 11794 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 292 | 0.030 |
Why?
| | Dexamethasone | 1 | 2019 | 365 | 0.030 |
Why?
| | Ficoll | 1 | 2016 | 4 | 0.030 |
Why?
| | Centrifugation, Density Gradient | 1 | 2016 | 36 | 0.030 |
Why?
| | Miniaturization | 1 | 2016 | 22 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2016 | 165 | 0.030 |
Why?
| | Cell Separation | 1 | 2016 | 306 | 0.030 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 82 | 0.030 |
Why?
| | Morbidity | 1 | 2015 | 322 | 0.030 |
Why?
| | CD4 Antigens | 1 | 2015 | 137 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 209 | 0.030 |
Why?
| | Neuropsychological Tests | 2 | 2009 | 1137 | 0.020 |
Why?
| | Acidosis | 1 | 2014 | 105 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2015 | 368 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 534 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2016 | 1165 | 0.020 |
Why?
| | Pregnancy | 2 | 2015 | 7216 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2014 | 356 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 1115 | 0.020 |
Why?
| | Temperature | 1 | 2014 | 633 | 0.020 |
Why?
| | Lymphocyte Activation | 1 | 2015 | 1133 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1378 | 0.020 |
Why?
| | Homeostasis | 1 | 2015 | 644 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 533 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 2094 | 0.020 |
Why?
| | Thrombosis | 1 | 2014 | 400 | 0.020 |
Why?
| | Social Behavior | 1 | 2013 | 284 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1300 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 910 | 0.020 |
Why?
| | Hemorrhage | 1 | 2014 | 822 | 0.020 |
Why?
| | Mental Processes | 1 | 2008 | 37 | 0.020 |
Why?
| | Disability Evaluation | 1 | 2009 | 311 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2015 | 2514 | 0.020 |
Why?
| | Verbal Learning | 1 | 2008 | 72 | 0.020 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 719 | 0.020 |
Why?
| | Semantics | 1 | 2008 | 96 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4151 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 381 | 0.020 |
Why?
| | Adult | 3 | 2023 | 40881 | 0.020 |
Why?
| | Regression Analysis | 1 | 2009 | 1001 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 4330 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2019 | 17330 | 0.010 |
Why?
| | Gene Silencing | 1 | 2007 | 202 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2009 | 8347 | 0.010 |
Why?
| | Memory | 1 | 2008 | 297 | 0.010 |
Why?
| | Memory, Short-Term | 1 | 2008 | 269 | 0.010 |
Why?
| | Age of Onset | 1 | 2007 | 557 | 0.010 |
Why?
| | Motor Activity | 1 | 2009 | 718 | 0.010 |
Why?
| | Caregivers | 1 | 2013 | 1074 | 0.010 |
Why?
| | Aged | 3 | 2009 | 26217 | 0.010 |
Why?
| | Middle Aged | 3 | 2009 | 36309 | 0.010 |
Why?
| | Disease Progression | 1 | 2007 | 2865 | 0.010 |
Why?
| | Cohort Studies | 1 | 2008 | 6033 | 0.010 |
Why?
|
|
Reynolds's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|